OrganiGram (CVE:OGI) Price Target Lowered to C$7.00 at Canaccord Genuity

OrganiGram (CVE:OGI) had its price target cut by equities researchers at Canaccord Genuity from C$8.50 to C$7.00 in a report issued on Wednesday, BayStreet.CA reports.

Several other analysts also recently weighed in on the stock. AltaCorp Capital lowered their target price on shares of OrganiGram from C$13.15 to C$6.50 in a report on Tuesday. CIBC set a C$9.00 target price on shares of OrganiGram and gave the company an “outperform” rating in a report on Tuesday, September 24th. Finally, Jefferies Financial Group raised shares of OrganiGram from a “hold” rating to a “buy” rating and lowered their target price for the company from C$10.50 to C$8.20 in a report on Friday, October 11th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. OrganiGram has a consensus rating of “Buy” and a consensus target price of C$8.60.

The stock has a market capitalization of $661.23 million and a P/E ratio of 28.02. The company has a fifty day moving average price of C$6.22 and a 200-day moving average price of C$7.97. The company has a current ratio of 9.06, a quick ratio of 4.14 and a debt-to-equity ratio of 14.71. OrganiGram has a fifty-two week low of C$4.11 and a fifty-two week high of C$11.30.

About OrganiGram

OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.

Featured Article: What are the benefits of a balanced fund?

Analyst Recommendations for OrganiGram (CVE:OGI)

Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.